Apixaban is a new drug that acts by
Rivaroxaban and Apixaban are newer oral anticoagulants that act by inhibiting factor Xa. Newer oral anticoagulants that are currently being asked in the exams are: Direct thrombin inhibitor- Dabigatran Direct factor Xa inhibitors Apixaban Rivaroxaban Edoxaban Betrixaban
Inhibiting TNF alpha
Inhibiting coagulation factor Xa
Inhibiting platelet aggregation
Activating plasminogen
Hematology